Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2010

01.09.2010 | Brief Report

Surgical treatment of breast cancer in young women

verfasst von: Antonio Piñero Madrona

Erschienen in: Breast Cancer Research and Treatment | Sonderheft 1/2010

Einloggen, um Zugang zu erhalten

Excerpt

Surgical treatment is a fundamental aspect in the proper management of breast cancer. It is not only the mainstay of loco-regional treatment, but it also allows disease staging and optimization of adjuvant chemotherapy through histopathological and immunohistochemical analysis of the biopsied tissue. …
Literatur
1.
Zurück zum Zitat Dow KH, Lafferty P (2000) Quality of life, survivorship, and psychosocial adjustment of young women with breast cancer after breast-conserving surgery and radiation therapy. Oncol Nurs Forum 27(10):1555–1564PubMed Dow KH, Lafferty P (2000) Quality of life, survivorship, and psychosocial adjustment of young women with breast cancer after breast-conserving surgery and radiation therapy. Oncol Nurs Forum 27(10):1555–1564PubMed
2.
Zurück zum Zitat Anders CK, Johnson R, Litton J, Phillips M, Bleyer A (2009) Breast cancer before age 40 years. Semin Oncol 36(3):237–249CrossRefPubMed Anders CK, Johnson R, Litton J, Phillips M, Bleyer A (2009) Breast cancer before age 40 years. Semin Oncol 36(3):237–249CrossRefPubMed
3.
Zurück zum Zitat Shannon C, Smith IE (2003) Breast cancer in adolescents and young women. Eur J Cancer 39(18):2632–2642CrossRefPubMed Shannon C, Smith IE (2003) Breast cancer in adolescents and young women. Eur J Cancer 39(18):2632–2642CrossRefPubMed
4.
Zurück zum Zitat Lalloo F, Varley J, Moran A, Ellis D, O’Dair L, Pharoah P et al (2006) BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Eur J Cancer 42(8):1143–1150CrossRefPubMed Lalloo F, Varley J, Moran A, Ellis D, O’Dair L, Pharoah P et al (2006) BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Eur J Cancer 42(8):1143–1150CrossRefPubMed
5.
Zurück zum Zitat Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80–87CrossRefPubMed Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80–87CrossRefPubMed
6.
Zurück zum Zitat Axelrod D, Smith J, Kornreich D, Grinstead E, Singh B, Cangiarella J et al (2008) Breast cancer in young women. J Am Coll Surg 206(6):1193–1203CrossRefPubMed Axelrod D, Smith J, Kornreich D, Grinstead E, Singh B, Cangiarella J et al (2008) Breast cancer in young women. J Am Coll Surg 206(6):1193–1203CrossRefPubMed
7.
Zurück zum Zitat de Bock GH, Putter H, Bonnema J, van der Hage JA, Bartelink H, van de Velde CJ (2009) The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model. Breast Cancer Res Treat 117(2):401–408CrossRefPubMed de Bock GH, Putter H, Bonnema J, van der Hage JA, Bartelink H, van de Velde CJ (2009) The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model. Breast Cancer Res Treat 117(2):401–408CrossRefPubMed
8.
Zurück zum Zitat van der Leest M, Evers L, van der Sangen MJ, Poortmans PM, van de Poll-Franse LV, Vulto AJ et al (2007) The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 years. Cancer 109(10):1957–1964CrossRefPubMed van der Leest M, Evers L, van der Sangen MJ, Poortmans PM, van de Poll-Franse LV, Vulto AJ et al (2007) The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 years. Cancer 109(10):1957–1964CrossRefPubMed
9.
Zurück zum Zitat Devolli-Disha E, Manxhuka-Kerliu S, Ymeri H, Kutllovci A (2009) Comparative accuracy of mammography and ultrasound in women with breast symptoms according to age and breast density. Bosn J Basic Med Sci 9(2):131–136PubMed Devolli-Disha E, Manxhuka-Kerliu S, Ymeri H, Kutllovci A (2009) Comparative accuracy of mammography and ultrasound in women with breast symptoms according to age and breast density. Bosn J Basic Med Sci 9(2):131–136PubMed
10.
Zurück zum Zitat Bharat A, Aft RL, Gao F, Margenthaler JA (2009) Patient and tumor characteristics associated with increased mortality in young women (< or = 40 years) with breast cancer. J Surg Oncol 100(3):248–251CrossRefPubMed Bharat A, Aft RL, Gao F, Margenthaler JA (2009) Patient and tumor characteristics associated with increased mortality in young women (< or = 40 years) with breast cancer. J Surg Oncol 100(3):248–251CrossRefPubMed
11.
Zurück zum Zitat Lenhard MS, Bauerfeind I, Untch M (2008) Breast cancer and pregnancy: challenges of chemotherapy. Crit Rev Oncol Hematol 67(3):196–203CrossRefPubMed Lenhard MS, Bauerfeind I, Untch M (2008) Breast cancer and pregnancy: challenges of chemotherapy. Crit Rev Oncol Hematol 67(3):196–203CrossRefPubMed
12.
Zurück zum Zitat Arriagada R, Le MG, Rochard F, Contesso G (1996) Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 14(5):1558–1564PubMed Arriagada R, Le MG, Rochard F, Contesso G (1996) Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 14(5):1558–1564PubMed
13.
Zurück zum Zitat Rustogi A, Budrukkar A, Dinshaw K, Jalali R (2005) Management of locally advanced breast cancer: evolution and current practice. J Cancer Res Ther 1(1):21–30CrossRefPubMed Rustogi A, Budrukkar A, Dinshaw K, Jalali R (2005) Management of locally advanced breast cancer: evolution and current practice. J Cancer Res Ther 1(1):21–30CrossRefPubMed
14.
Zurück zum Zitat Newman LA (2008) Surgical issues and preoperative systemic therapy. Cancer Treat Res 141:79–98CrossRefPubMed Newman LA (2008) Surgical issues and preoperative systemic therapy. Cancer Treat Res 141:79–98CrossRefPubMed
15.
Zurück zum Zitat Mameri CS, Kemp C, Goldman SM, Sobral LA, Ajzen S (2008) Impact of breast MRI on surgical treatment, axillary approach, and systemic therapy for breast cancer. Breast J 14(3):236–244CrossRefPubMed Mameri CS, Kemp C, Goldman SM, Sobral LA, Ajzen S (2008) Impact of breast MRI on surgical treatment, axillary approach, and systemic therapy for breast cancer. Breast J 14(3):236–244CrossRefPubMed
16.
Zurück zum Zitat Franceschini G, Magno S, Fabbri C, Chiesa F, Di Leone A, Moschella F et al (2008) Conservative and radical oncoplastic approaches in the surgical treatment of breast cancer. Eur Rev Med Pharmacol Sci 12(6):387–396PubMed Franceschini G, Magno S, Fabbri C, Chiesa F, Di Leone A, Moschella F et al (2008) Conservative and radical oncoplastic approaches in the surgical treatment of breast cancer. Eur Rev Med Pharmacol Sci 12(6):387–396PubMed
17.
Zurück zum Zitat Eldor L, Spiegel A (2009) Breast reconstruction after bilateral prophylactic mastectomy in women at high risk for breast cancer. Breast J 15(Suppl 1):S81–S89CrossRefPubMed Eldor L, Spiegel A (2009) Breast reconstruction after bilateral prophylactic mastectomy in women at high risk for breast cancer. Breast J 15(Suppl 1):S81–S89CrossRefPubMed
18.
Zurück zum Zitat Kronowitz SJ, Robb GL (2009) Radiation therapy and breast reconstruction: a critical review of the literature. Plast Reconstr Surg 124(2):395–408CrossRefPubMed Kronowitz SJ, Robb GL (2009) Radiation therapy and breast reconstruction: a critical review of the literature. Plast Reconstr Surg 124(2):395–408CrossRefPubMed
19.
Zurück zum Zitat Fernández-Frías AM, Aguilar J, Sánchez JA, Merck B, Piñero A, Calpena R (2009) Immediate reconstruction after mastectomy for breast cancer: which factors affect its course and final outcome? J Am Coll Surg 208(1):126–133CrossRefPubMed Fernández-Frías AM, Aguilar J, Sánchez JA, Merck B, Piñero A, Calpena R (2009) Immediate reconstruction after mastectomy for breast cancer: which factors affect its course and final outcome? J Am Coll Surg 208(1):126–133CrossRefPubMed
20.
Zurück zum Zitat Cense HA, Rutgers EJ, Lopes Cardozo M, Van Lanschot JJ (2001) Nipple-sparing mastectomy in breast cancer: a viable option? Eur J Surg Oncol 27(6):521–526CrossRefPubMed Cense HA, Rutgers EJ, Lopes Cardozo M, Van Lanschot JJ (2001) Nipple-sparing mastectomy in breast cancer: a viable option? Eur J Surg Oncol 27(6):521–526CrossRefPubMed
22.
Zurück zum Zitat Paepke S, Schmid R, Fleckner S, Paepke D, Niemeyer M, Schmalfeldt B et al (2009) Subcutaneous mastectomy with conservation of the nipple-areola skin: broadening the indications. Ann Surg 250(2):288–292CrossRefPubMed Paepke S, Schmid R, Fleckner S, Paepke D, Niemeyer M, Schmalfeldt B et al (2009) Subcutaneous mastectomy with conservation of the nipple-areola skin: broadening the indications. Ann Surg 250(2):288–292CrossRefPubMed
23.
Zurück zum Zitat Lyman GH, Giuliano AE, Somerfield MR, Benson AB III, Bodurka DC, Burstein HJ et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703–7720CrossRefPubMed Lyman GH, Giuliano AE, Somerfield MR, Benson AB III, Bodurka DC, Burstein HJ et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703–7720CrossRefPubMed
24.
Zurück zum Zitat Mondi MM, Cuenca RE, Ollila DW, Stewart JH Jr, Levine EA (2007) Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol 14(1):218–221CrossRefPubMed Mondi MM, Cuenca RE, Ollila DW, Stewart JH Jr, Levine EA (2007) Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol 14(1):218–221CrossRefPubMed
25.
Zurück zum Zitat Ruiterkamp J, Ernst MF, van de Poll-Franse LV, Bosscha K, Tjan-Heijnen VC, Voogd AC (2009) Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol 35(11):1146–1151PubMed Ruiterkamp J, Ernst MF, van de Poll-Franse LV, Bosscha K, Tjan-Heijnen VC, Voogd AC (2009) Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol 35(11):1146–1151PubMed
26.
Zurück zum Zitat Durán JD, Bellón JM (2007) Papel de la cirugía en las metástasis del cáncer de mama. Cir Esp 82(1):3–10CrossRefPubMed Durán JD, Bellón JM (2007) Papel de la cirugía en las metástasis del cáncer de mama. Cir Esp 82(1):3–10CrossRefPubMed
Metadaten
Titel
Surgical treatment of breast cancer in young women
verfasst von
Antonio Piñero Madrona
Publikationsdatum
01.09.2010
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe Sonderheft 1/2010
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-1038-1

Weitere Artikel der Sonderheft 1/2010

Breast Cancer Research and Treatment 1/2010 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

ASS schützt nicht vor Brustkrebsrezidiven

02.05.2024 Mammakarzinom Nachrichten

Nützt nichts und ist vielleicht sogar schädlich: In einer Phase-3-Studie konnten täglich 300 mg ASS keine Brustkrebsrezidive bei Frauen vermeiden, die ein hohes Risiko für eine Tumorrückkehr aufwiesen. Tendenziell traten unter ASS sogar häufiger Rezidive auf als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.